Measurement of reactive oxygen species by chemiluminescence in diet-induced atherosclerosis: Protective roles of vitamin E and probucol on different radical species

International Journal of Clinical and Laboratory Research

Volumn 28, Issue 2, 1998, Pages 122-126

  Haklar, G ^a   Sirikci O ^a   Ozer N K ^a   Yalcin A S ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Chemiluminescence; Probucol; Superoxide radical; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; PEROXIDASE; PROBUCOL; REACTIVE OXYGEN METABOLITE;

ANIMAL; AORTA; ARTERIOSCLEROSIS; ARTICLE; BLOOD; CHEMOLUMINESCENCE; CHOLESTEROL INTAKE; ENZYMOLOGY; MALE; METABOLISM; RABBIT;

ANIMALS; AORTA; ARTERIOSCLEROSIS; CHEMILUMINESCENT MEASUREMENTS; CHOLESTEROL; CHOLESTEROL, DIETARY; MALE; PEROXIDASE; PROBUCOL; RABBITS; REACTIVE OXYGEN SPECIES; VITAMIN E;

ANIMALIA; LETHRINIDAE; ORYCTOLAGUS CUNICULUS;

EID: 0031855785     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050031     Document Type: Article

References (39)

1. Aviram M. Modified forms of LDL and atherosclerosis. Atherosclerosis 1993; 98: 1.
2. Penn MS, Chisolm GM. Oxidized lipoproteins, altered cell function and atherosclerosis. Atherosclerosis 1994; 108 [Suppl]: S21.
3. Prasad K, Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 1993; 125: 958.
4. Frei B. Reactive oxygen species and antioxidant vitamins: mechanism of action. Am J med 1994; 97 [Suppl 3A]: 5S.
5. Kontos HA, Wei EP, Elli EF, Jenkins LW, Povlishock JT, Rowe GT, Hess ML. Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandins in cats. Circ Res 1985; 57: 142.
6. Sligar SG, Lipscomb JD, Debrunner PG, Gunsalus IC. Superoxide anion production by the autoxidation of cytochrome P450. Biochem Biophys Res Commun 1974: 61: 290.
7. Loschen G, Azzi A, Richter C, Flohe L. Superoxide radicals as precursors of mitochondrial hydrogen peroxide. FEBS Lett 1974; 42: 68.
8. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546.
9. Minor RL Jr, Myers PR, Guerra R Jr, Bates JN, Harrison DG. Diet induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 1990; 86: 2109.
10. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman MA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620
11. Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett 1995; 369: 131.
12. Van Dyke K, Castranova V, eds. Cellular chemiluminescence. CRC Press, London: 1987.
13. Halliwell B, Grootveld M. The measurement of free radical reactions in humans. FEBS Lett 1987; 213: 9.
14. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546.
15. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 1987; 84: 7725.
16. Grisham MB, Jefferson MM, Melton DF, Thomas EL. Chlorination of endogenous amines by isolated neutrophils. J Biol Chem 1984; 259: 10404.
17. Nierenberg DW, Nann SL. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am J Clin Nut 1992; 56: 417.
18. Elinder LS, Walldius G. Determination of plasma probucol by HPLC. J Lipid Res, 1992; 33: 131
19. Araujo FB, Barbosa DS, Hsin CY, Maranhao RC, Abdalla DSP. Evaluation of oxidant stress in patients with hyperlipidemia. Atherosclerosis 1995; 117 61.
20. Badwey JA, Curnutte JT, Karnovsky ML. cis-Polyunsaturated fatty acids induce high levels of superoxide production by human neutrophils. J Biol Chem 1989; 256. 12640.
21. Elneihoum AM, Falke P, Hedland B, Lindgarde F, Ohlsson K. Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis 1997; 131: 79.
22. Heim KF, Thomas G, Ramwell PW. Superoxide production in the isolated rabbit aorta and the effect of alloxan, indomethacin, and nitrovasodilators. J Pharm Exp Ther 1991; 256: 537
23. Böger RH, Bode-Böger SM, Mügge A, Kienke S, Brandes R, Dwenger A, Frölich JC. Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis, 1995; 117: 273.
24. Böger RH, Bode-Böger SM, Frölich JC. The arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications. Atherosclerosis 1996; 127: 1.
25. Mügge A, Elwell JH, Peterson TE, Harrison DG Release of intact EDRF depends on endothelial SOD activity Am J Physiol 1991, 260: C219.
26. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454.
27. Steinberg D. Role of oxidized LDL and antioxidants in atherosclerosis. Adv Exp Med Biol 1995; 369 39.
28. Fruebis J, Steinberg D, Dresel HA, Carew TE. A comparison of the antiatherogenic effects of probucol and a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits. J Clin Invest 1994; 94: 392.
29. Kleinveld HA, Demacker PNM, Stalenhoef AFH. Comparative study on the effect of low dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb 1994; 14: 1386.
30. Regnström J, Walldius G, Nilsson S, Elinder LS, Johansson J, Mölgaard J, Holme I, Olsson AG, Nilsson J. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis. Atherosclerosis 1996; 125: 209.
31. Duvojne CA, Harris WS, Colle Gerrond LL, Fan J, Muzio F. Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia. Am J Cardiol 1994; 74: 38.
32. Paterson JR, Rumley AG, Oldroyd KG, Tait GW, Smellie WSA, Packard JC, Shephard J, Lorimer AR. Probucol reduces plasma lipid peroxides in man. Atherosclerosis 1992; 97: 63.
33. Fruebis J, Carew TE, Palinski W. Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits. Atherosclerosis 1995; 117: 217.
34. Stephans NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781.
35. Kuzuya M, Naito M, Funaki C, Hayashi T, Asai K, Kuzuya F. Probucol prevents oxidation injury to endothelial cells. J Lipid Res 1991; 32: 197.
36. Devaraj S, Li D, Jialal I. The effects of alpha tocopherol supplementation on monocyte function. J Clin Invest 1996; 98: 756.
37. Stein Y, Stein O, Delplangue B, Fesmire JD, Lee DM, Alauporic P. Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels. Atherosclerosis 1989; 102: 145.
38. Negre-Salvayre A, Alomar Y, Truly M, Salvayre R. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways. Biochim Biophys Acta 1991; 1096: 291.
39. Gotoh N, Shimizu K, Komuro E, Tsuchiya J, Noguchi N, Niki E. Antioxidant activities of probucol against lipid perioxidation. Biochim Biophys Acta 1992; 1128: 147.